Justina Pajarskienė
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Justina Pajarskienė has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aida Kaušylė
State Research Institute Centre for Innovative Medicine
1 shared publication - Alexei Verkhratsky
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
1 shared publication - Augustas Pivoriūnas
Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
1 shared publication - Dmitry Lim
Department of Pharmaceutical Sciences, University Amedeo Avogadro of Piemonte Orientale, Novara, Italy
1 shared publication - Karolina Kriaučiūnaitė
State Research Institute Centre for Innovative Medicine
1 shared publication - Virginijus Tunaitis
Department of Stem Cell Biology, State Research Institute Centre for Innovative Medicine, LT-01102 Vilnius, Lithuania
1 shared publication
Latest Publications
- Open Access
Immortalised hippocampal astrocytes from 3xTG-AD mice fail to support BBB integrity in vitro : Role of extracellular vesicles in glial-endothelial communication
Impairments of the blood brain barrier (BBB) and vascular dysfunction contribute to Alzheimer’s disease (AD) from the earliest stages. However, the effects of AD-affected astrocytes on the BBB remain largely unexplored. In the present study we created an in vitro BBB using human immortalised endothelial cells in combination with immortalised astroglial cell lines from the hippocampus of 3xTG-AD and wild-type mice (3Tg-iAstro and WT-iAstro, respectively). We found that co-culturing endothelial monolayers with WT-iAstro up-regulates expression of endothelial tight junction proteins (claudin-5, occludin, ZO-1) and increases the trans-endothelial electrical resistance (TEER). In contrast, co-culturing with 3Tg-iAstro does not affect expression of tight junction proteins and does not change the TEER of endothelial monolayers. The same in vitro model has been used to evaluate the effects of extracellular vesicles (EVs) derived from the WT-iAstro and 3Tg-iAstro. The EVs derived from WT-iAstro increased TEER and up-regulated expression of tight junction proteins, whereas EVs from 3Tg-iAstro were ineffective. In conclusion, we show for the first time that immortalised hippocampal astrocytes from 3xTG-AD mice exhibit impaired capacity to support BBB integrity in vitro through paracrine mechanisms and may represent an important factor underlying vascular abnormalities during development of AD.
Open AccessImmortalised hippocampal astrocytes from 3xTG-AD mice fail to support BBB integrity in vitro : Role of extracellular vesicles in glial-endothelial communication
Impairments of the blood brain barrier (BBB) and vascular dysfunction contribute to Alzheimer’s disease (AD) from the earliest stages. However, the effects of AD-affected astrocytes on the BBB remain largely unexplored. In the present study we created an in vitro BBB using human immortalised endothelial cells in combination with immortalised astroglial cell lines from the hippocampus of 3xTG-AD and wild-type mice (3Tg-iAstro and WT-iAstro, respectively). We found that co-culturing endothelial monolayers with WT-iAstro up-regulates expression of endothelial tight junction proteins (claudin-5, occludin, ZO-1) and increases the trans-endothelial electrical resistance (TEER). In contrast, co-culturing with 3Tg-iAstro does not affect expression of tight junction proteins and does not change the TEER of endothelial monolayers. The same in vitro model has been used to evaluate the effects of extracellular vesicles (EVs) derived from the WT-iAstro and 3Tg-iAstro. The EVs derived from WT-iAstro increased TEER and up-regulated expression of tight junction proteins, whereas EVs from 3Tg-iAstro were ineffective. In conclusion, we show for the first time that immortalised hippocampal astrocytes from 3xTG-AD mice exhibit impaired capacity to support BBB integrity in vitro through paracrine mechanisms and may represent an important factor underlying vascular abnormalities during development of AD.